| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.11 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |